ZRSR1 co-operates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells.

Autor: Madan V; Cancer Science Institute of Singapore, National University of Singapore, Singapore. vikasmadan@aol.com., Cao Z; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Teoh WW; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Dakle P; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Han L; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Shyamsunder P; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore., Jeitany M; Cancer Science Institute of Singapore, National University of Singapore, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore., Zhou S; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Li J; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Nordin HBM; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Shi J; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Yu S; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Yang H; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Hossain MZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Chng WJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Hematology-Oncology, National University Cancer Institute, NUHS, Singapore., Koeffler HP; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Cedars-Sinai Medical Center, Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, USA; National University Cancer Institute, National University Hospital Singapore, Singapore.

Publikováno v: Haematologica [Haematologica] 2022 Mar 01; Vol. 107 (3), pp. 680-689. Date of Electronic Publication: 2022 Mar 01.

ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion.

Autor: Madan V; Cancer Science Institute of Singapore, National University of Singapore csivm@nus.edu.sg nhattor@med.showa-u.ac.jp sly7012@cgmh.org.tw., Han L; Cancer Science Institute of Singapore, National University of Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore., Hattori N; Cancer Science Institute of Singapore, National University of Singapore csivm@nus.edu.sg nhattor@med.showa-u.ac.jp sly7012@cgmh.org.tw.; Division of Hematology, Department of Medicine, School of Medicine, Showa University, Shinagawa-Ku, Tokyo, Japan., Teoh WW; Cancer Science Institute of Singapore, National University of Singapore., Mayakonda A; Cancer Science Institute of Singapore, National University of Singapore., Sun QY; Cancer Science Institute of Singapore, National University of Singapore., Ding LW; Cancer Science Institute of Singapore, National University of Singapore., Nordin HBM; Cancer Science Institute of Singapore, National University of Singapore., Lim SL; Cancer Science Institute of Singapore, National University of Singapore., Shyamsunder P; Cancer Science Institute of Singapore, National University of Singapore., Dakle P; Cancer Science Institute of Singapore, National University of Singapore., Sundaresan J; Cancer Science Institute of Singapore, National University of Singapore., Doan NB; Department of Pathology and Laboratory Medicine, Santa Monica-University of California-Los Angeles Medical Center, Los Angeles, CA, USA., Sanada M; Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan.; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan., Sato-Otsubo A; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan., Meggendorfer M; MLL Munich Leukemia Laboratory, Germany., Yang H; Cancer Science Institute of Singapore, National University of Singapore., Said JW; Department of Pathology and Laboratory Medicine, Santa Monica-University of California-Los Angeles Medical Center, Los Angeles, CA, USA., Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan., Haferlach T; MLL Munich Leukemia Laboratory, Germany., Liang DC; Division of Pediatric Hematology-Oncology, Mackay Memorial Hospital and Mackay Medical College, Taipei, Taiwan., Shih LY; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan csivm@nus.edu.sg nhattor@med.showa-u.ac.jp sly7012@cgmh.org.tw., Nakamaki T; Division of Hematology, Department of Medicine, School of Medicine, Showa University, Shinagawa-Ku, Tokyo, Japan., Wang QT; Department of Biological Sciences, University of Illinois at Chicago, IL, USA., Koeffler HP; Cancer Science Institute of Singapore, National University of Singapore.; Cedars-Sinai Medical Center, Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, CA, USA.; Department of Hematology-Oncology, National University Cancer Institute of Singapore (NCIS), National University Hospital, Singapore.

Publikováno v: Haematologica [Haematologica] 2018 Dec; Vol. 103 (12), pp. 1980-1990. Date of Electronic Publication: 2018 Aug 09.